Copyright
©The Author(s) 2019.
World J Clin Cases. Aug 26, 2019; 7(16): 2287-2301
Published online Aug 26, 2019. doi: 10.12998/wjcc.v7.i16.2287
Published online Aug 26, 2019. doi: 10.12998/wjcc.v7.i16.2287
Table 1 Characteristics of included trials and patients
First author, year | Size | Intraoperative ambient temperature | Type of anesthesia | Administration method | Local anesthetic | Intervention | Outcomes |
Palmer et al[15], 1995 | 28 | Unclear | SA | Intrathecal | 5% lidocaine | Fentanyl vs Placebo | ③④ |
Shehabi et al[16], 1990 | 62 | 21 °C | EA | Extradural | 0.5% bupivacaine | Fentanyl vs Placebo | ① |
Han et al[17], 2014 | 60 | Unclear | EA | Extradural | 0.75% ropivacaine | Fentanyl vs Dexmedetomidine vs Placebo | ③ |
Shami et al[34], 2016 | 150 | 24-26 °C | CSEA | Intrathecal | 0.5% hyperbaric bupivacaine | Pethidine vs Placebo | ③④⑤⑥ |
Techanivate et al[33], 2005 | 60 | 23 °C | SA | Intrathecal | 0.5% hyperbaric bupivacaine plus 0.2 mg morphine | Fentanyl vs Placebo | ③④⑤⑥ |
Roy et al[18], 2004 | 40 | 21–23 °C | SA | Intrathecal | 0.75% hyperbaric bupivacaine plus 0.15 mg morphine | Pethidine vs Placebo | ① |
Qi et al[19], 2016 | 118 | Unclear | SA | Intrathecal | 0.5% bupivacaine | Dexmedetomidine vs Morphine vs Placebo | ③④ |
Chen et al[31], 2010 | 64 | Unclear | SA | Intrathecal | 0.75% ropivacaine | Sufentanil vs Placebo | ③④⑤⑥ |
Bachmann-Mennenga et al[21], 2005 | 60 | Unclear | EA | Extradural | 1% ropivacaine | Sufentanil vs Placebo | ③④⑤⑥ |
Abdollahpour et al[10], 2015 | 75 | Unclear | SA | Intrathecal | 0.5% bupivacaine | Midazolam vs Sufentani vs Placebo | ③⑤ |
He et al[7], 2017 | 90 | 22–28 °C | SA | Intrathecal | 0.5% hyperbaric bupivacaine | Dexmedetomidine vs Placebo | ③④⑥ |
Nasseri et al[22], 2017 | 50 | 22–26 °C | SA | Intrathecal | 0.5% hyperbaric bupivacaine | Dexmedetomidine vs Placebo | ③⑤⑥ |
de Figueiredo Locks et al[3], 2012 | 80 | Unclear | SA | Intrathecal | 0.5% hyperbaric bupivacaine | Sufentanil vs Placebo | ① |
Rastegarian et al[9], 2013 | 100 | Unclear | SA | Intrathecal | 5% hyperbaric lidocaine | Pethidine vs Placebo | ③④⑤⑥ |
Khan et al[6], 2011 | 72 | 21–23 °C | SA | Intrathecal | 0.5% hyperbaric bupivacaine | Pethidine vs Placebo | ③⑤⑥ |
Hong et al[23], 2005 | 120 | 23–25 °C | CSEA | Intrathecal | 0.5% bupivacaine | Morphine vs Pethidine vs Placebo | ① |
Agrawal et al[24], 2016 | 60 | Unclear | SA | Intrathecal | 0.3% bupivacaine | Morphine vs Fentanyl vs Placebo | ③④⑤⑥ |
Hanoura et al[25], 2013 | 50 | Unclear | CSEA | Extradural | 0.5% hyperbaric bupivacaine (intrathecal) 0.25% bupivacaine plus 100ug fentanyl (extradural) | Dexmedetomidine vs Placebo | ③④⑤⑥ |
Anaraki et al[26], 2012 | 156 | 21–23°C | SA | Intrathecal | 0.5% hyperbaric bupivacaine | Pethidine vs Placebo | ③④⑥ |
Bajwa et al[27], 2012 | 100 | Unclear | SA | Intrathecal | 0.5% hyperbaric bupivacaine | Clonidine vs Placebo | ③④ |
Bi et al[28], 2017 | 60 | Unclear | CSEA | Intrathecal | 0.5% bupivacaine | Dexmedetomidine vs Placebo | ③④ |
Yousef et al[29], 2010 | 90 | Unclear | CSEA | Extradural | 0.5% hyperbaric bupivacaine (intrathecal) 0.25% bupivacaine plus 100ug fentanyl (extradural) | Magnesium sulfate vs Placebo | ③④⑤ |
Subedi et al[30], 2013 | 77 | Unclear | SA | Intrathecal | 0.5% hyperbaric bupivacaine | Tramadol vs Fentanyl | ④⑤⑥ |
Qian et al[31], 2008 | 80 | Unclear | CSEA | Intrathecal | 0.6% ropivacaine | Sufentanil vs Placebo | ③④⑤⑥ |
Faiz et al[8], 2013 | 72 | 23–25 °C | SA | Intrathecal | 0.5% bupivacaine | Magnesium sulfate vs Placebo | ① |
Sadegh et al[32], 2011 | 80 | 24 °C | SA | Intrathecal | 0.5% hyperbaric bupivacaine | Fentanyl vs Placebo | ①②③⑤ |
- Citation: Zhang YW, Zhang J, Hu JQ, Wen CL, Dai SY, Yang DF, Li LF, Wu QB. Neuraxial adjuvants for prevention of perioperative shivering during cesarean section: A network meta-analysis following the PRISMA guidelines. World J Clin Cases 2019; 7(16): 2287-2301
- URL: https://www.wjgnet.com/2307-8960/full/v7/i16/2287.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v7.i16.2287